Biocon's board to mull fund raising plans on 4 April
Biocon announced that its board is scheduled to meet on 4 April 2025 to consider raising funds through issuance of commercial papers (CP) or through any other mode via private placement basis.
US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks
Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...
EquityBulls12h
Syngene International Limited appoints Mr. Peter Bains as MD & CEO
The Board of Directors of Syngene International Limited has approved the appointment of Mr. Peter Bains as an Additional ...
Rediff Money12h
Board Meeting Intimation for Intimation For The Board...
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/04/2025 ,inter alia, to consider and approve Intimation of Board meeting for raising funds throu ...
Nifty Pharma extends losses for a fifth session as generics players fret over tariff deadline
Currently, US charges nearly zero duty on pharmaceutical imports, while India imposes around 10 percent tax on pharma imports ...
Stock market update: Nifty Pharma index falls 0.29% in a weak market
AM(IST)on Tuesday in a weak market. Dr. Reddy's Laboratories Ltd.(up 1.46 per cent), Biocon Ltd.(up 1.35 per cent), Natco ...